QUALITY PARAMETERS COMPARISON BETWEEN SIMILAR AND GENERIC ATENOLOL TABLETS AND THE REFERENCE PRODUCT
Abstract
Pharmaceutical equivalence between two medicinal products corresponds to the proof that both contain the same drug, i.e., the same active ingredient or salt, the same concentration, pharmaceutical form and route of administration, containing or not identical excipients. Tests conducted on comparative quality analysis include physico-chemical tests and when applicable, microbiological, and biological tests. This study evaluated the quality parameters of two brands of generic (called D and E) and two brands of similar (B and C) were evaluated in relation to the reference drug (A) of atenolol 50 mg. Tests of weight variation, friability, disintegration and assay were performed. In addition, microbiological control of the samples was performed by counting the total number of mesophilic microorganisms. The result was that there was no growth of colonies. All samples tested met the requirements of the tests performed according to the parameters described in the Brazilian Pharmacopeia 6th edition.
Keywords
Full Text:
PDF (Português (Brasil))DOI: http://dx.doi.org/10.14450/2318-9312.v32.e4.a2020.pp366-373
Refbacks
- There are currently no refbacks.
Copyright (c) 2020 Daniela Cristina de Medeiros Araújo
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Infarma - Ciências Farmacêuticas
ISSN - 2318-9312 (Versão eletrônica)
ISSN - 0104-0219 (Versão impressa)
Conselho Federal de Farmácia - CFF
SHIS QI 15 Lote "L" - Lago Sul - Brasília - DF
CEP: 71635-615 - Fone: (61)3878-8751
e-mail:infarma@cff.org.br
Diretoria
Walter da Silva Jorge João, Presidente do Conselho Federal de Farmácia
Lenira da Silva Costa, Vice-Presidente do Conselho Federal de Farmácia
João Samuel de Morais Meira, Tesoureiro do Conselho Federal de Farmácia
Luiz Gustavo de Freitas Pires, Secretário-Geral do Conselho Federal de Farmácia